Search research articles
Contact Us
Filters
Showing results (31-40 of 100) with videos related to
Page
of 10
Sort By:
Journal of Neuroinflammation
|
December 19, 2013
The neurotrophic hepatocyte growth factor attenuates CD8+ cytotoxic T-lymphocyte activity
Mahdia Benkhoucha, Nicolas Molnarfi, Gregory Schneiter, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
February 26, 2011
Pulse interleukin-2 with famotidine induces CD56+ lymphocytes in the peripheral blood of patients with metastatic melanoma or kidney cancer
Walter D Y Quan, Gregory A Gagnon, Paul R Walker, et al.
Springerplus
|
April 1, 2014
Effect of an exercise training intervention with resistance bands on blood cell counts during chemotherapy for lung cancer: a pilot randomized controlled trial
Kristina H Karvinen, David Esposito, Thomas D Raedeke, et al.
Current Opinion in Pharmacology
|
March 5, 2019
Peptides as cancer vaccines
Marta Calvo Tardón, Mathilde Allard, Valérie Dutoit, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
February 27, 2008
Low-dose cyclophosphamide and continuous-infusion interleukin-2 with famotidine in previously treated metastatic melanoma or kidney cancer
Walter D Y Quan, Francine M Quan, Linda A King, et al.
Plos One
|
April 14, 2016
Glioma Stemlike Cells Enhance the Killing of Glioma Differentiated Cells by Cytotoxic Lymphocytes
Esen Yonca Bassoy, Valentina Chiusolo, Guillaume Jacquemin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 10, 2023
Radio-chemotherapy of glioblastoma cells promotes phagocytosis by macrophages in vitro
Marc Lecoultre, Sylvie Chliate, Felipe I Espinoza, et al.
The American Journal of the Medical Sciences
|
October 7, 2014
Weighing projections of physical decline in lung cancer surgery decisions
Samuel Cykert, Paul R Walker, Lloyd J Edwards, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 20, 2013
Phase II study of low-dose paclitaxel with timed thoracic radiotherapy followed by adjuvant gemcitabine and carboplatin in unresectable stage III non-small cell lung cancer
Jun Zhang, Hiram A Gay, Suzanne Russo, et al.
Immunology Letters
|
February 20, 2002
Sister cytotoxic CD8+ T cell clones differing in natural killer inhibitory receptor expression in human astrocytoma
Gaëlle Perrin, Daniel Speiser, Andrée Porret, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 100) with videos related to
Sort By:
Page
of 10
Journal of Neuroinflammation
|
December 19, 2013
The neurotrophic hepatocyte growth factor attenuates CD8+ cytotoxic T-lymphocyte activity
Mahdia Benkhoucha, Nicolas Molnarfi, Gregory Schneiter, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
February 26, 2011
Pulse interleukin-2 with famotidine induces CD56+ lymphocytes in the peripheral blood of patients with metastatic melanoma or kidney cancer
Walter D Y Quan, Gregory A Gagnon, Paul R Walker, et al.
Springerplus
|
April 1, 2014
Effect of an exercise training intervention with resistance bands on blood cell counts during chemotherapy for lung cancer: a pilot randomized controlled trial
Kristina H Karvinen, David Esposito, Thomas D Raedeke, et al.
Current Opinion in Pharmacology
|
March 5, 2019
Peptides as cancer vaccines
Marta Calvo Tardón, Mathilde Allard, Valérie Dutoit, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
February 27, 2008
Low-dose cyclophosphamide and continuous-infusion interleukin-2 with famotidine in previously treated metastatic melanoma or kidney cancer
Walter D Y Quan, Francine M Quan, Linda A King, et al.
Plos One
|
April 14, 2016
Glioma Stemlike Cells Enhance the Killing of Glioma Differentiated Cells by Cytotoxic Lymphocytes
Esen Yonca Bassoy, Valentina Chiusolo, Guillaume Jacquemin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 10, 2023
Radio-chemotherapy of glioblastoma cells promotes phagocytosis by macrophages in vitro
Marc Lecoultre, Sylvie Chliate, Felipe I Espinoza, et al.
The American Journal of the Medical Sciences
|
October 7, 2014
Weighing projections of physical decline in lung cancer surgery decisions
Samuel Cykert, Paul R Walker, Lloyd J Edwards, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 20, 2013
Phase II study of low-dose paclitaxel with timed thoracic radiotherapy followed by adjuvant gemcitabine and carboplatin in unresectable stage III non-small cell lung cancer
Jun Zhang, Hiram A Gay, Suzanne Russo, et al.
Immunology Letters
|
February 20, 2002
Sister cytotoxic CD8+ T cell clones differing in natural killer inhibitory receptor expression in human astrocytoma
Gaëlle Perrin, Daniel Speiser, Andrée Porret, et al.
Page
of 10